Severe cutaneous anthrax with systemic complications: a case report
-
By
-
Uinkul Izbanova
-
Amangul Duisenova
-
Gulnara Tokmurziyeva
-
Aigul Abdrakhmanova
-
Saltanat Aibosynova
-
Bakhyt Kosherova
-
Ravilya Yegemberdiyeva
-
Ainur Sadykova
-
Saule Umarova
-
Daulet Askarov
-
Olzhas Rashkanov
-
Manshuk Sydykova
-
Aisazhan Yussupov
-
Altyn Rysbekova
-
Nur Tukhanova
-
May 20, 2026
-
Clinical Scorecard: A Case of Severe Cutaneous Anthrax Complicated by Systemic Manifestations
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | |
| Target Population | Individuals in endemic regions, particularly those involved in agricultural activities and at risk of exposure to infected animals. |
| Care Setting | |
Key Highlights
- Progression from cutaneous to systemic anthrax can occur, leading to severe complications.
- Early diagnosis and treatment are critical for favorable outcomes.
- Molecular diagnostics (PCR) are essential for rapid confirmation of Bacillus anthracis.
- Implementing biosafety measures in agricultural settings is crucial to prevent transmission.
Guideline-Based Recommendations
Diagnosis
Management
- Initiate antimicrobial therapy promptly upon suspicion of anthrax, using recommended agents such as ciprofloxacin or doxycycline.
- Escalate treatment in cases of systemic involvement and complications.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Early initiation of appropriate antimicrobial therapy, such as ciprofloxacin or doxycycline, is crucial to prevent progression.
Clinical Best Practices
- Recognize early signs of cutaneous anthrax and initiate treatment without delay.
- Utilize molecular diagnostics for rapid identification of Bacillus anthracis in severe cases.
- Implement strict biosafety measures in agricultural settings to prevent transmission.
- Educate the public on anthrax prevention and the importance of reporting potential exposures.
Related Resources & Content
